Nephrology News

SAN DIEGO — Help with transportation, copays and treatment adherence were the top three needs affecting health care according to a group of patients participating in a lupus navigator pilot program.

SAN DIEGO — Among African American and white adults with obesity who received kidneys from the same deceased donor, graft failure rates were higher — but so were survival rates — for African American recipients, according to study data.

SAN DIEGO — Health care providers and advocates must confront social disparities among patients with kidney disease to improve the standard of care, American Society of Nephrology President Deidra C. Crews, MD, ScM, FASN, said.

SAN DIEGO — Genetic evaluation of patients referred to a U.S. glomerular disease center revealed a genetic diagnosis in 35% of cases, informing prognosis and treatment and allowing for family testing, among other benefits.

SAN DIEGO — Nearly 75% of kidney transplant recipients at a U.S. hospital who survived at least 1 year did not see a primary care provider in the years following the procedure, according to study data.

The FDA has granted rare pediatric disease designation to Omeros Corporation’s zaltenibart for the treatment of complement 3 glomerulopathy, according to a press release.

SAN DIEGO — Access to home dialysis among patients with disabilities with end-stage kidney disease decreased during the COVID-19 pandemic, according to data presented here at ASN Kidney Week.

SAN DIEGO — Patients who were hospitalized during the omicron variant wave were less likely to develop AKI compared with patients who had previous waves of SARS-CoV-2 infection, according to data presented at ASN Kidney Week, here.

In these videos, Koyal Jain, MD, MPH, FASN, associate professor of medicine and director, nephrology and hypertension training program at UNC School of Medicin, discusses the latest advancements in glomerular diseases.

SAN DIEGO — In this video exclusive from ASN Kidney Week, Jeffrey Giullian, MD, MBA, FASN, chief medical officer of DaVita, discusses three pressing regulatory issues for nephrology stakeholders.